Virmmac.com --- CBIS News Alert!

July 5, 2010 - PRLog -- Lapeer, Michigan: Virmmac.com and Stocktalk101.com announced today the upcoming live interview with CEO Robert Jean Melamede of Cannabis Science, Inc, , Wednesday, July 7, 2010 at 1pm Est.

You can listen to the live broadcast at http://www.stocktalk101.com or http://www.virmmac.com

Shareholders and interested parties can direct questions to info@virmmac.com prior to the live interview for submission.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development.  The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, they are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Virmmac.com, a virtual IR, marketing, media, and administration center focused on providing companies ongoing support while in or not presently in promotion, and Stocktalk101.com, designed to educate traders and investors alike in how to be successful in playing the OTC or Pink sheet companies.  

This interview will be available in archive immediately  upon conclusion of the live broadcast on both Virmmac’s (www.virmmac.com) and Stocktalk101’s (www.stocktalk101.com) homepage.

Copyright (C) 2010 All right reserved

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Disclaimer: Verify all claims and do your own due diligence. Virmmac.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Virmmac.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Virmmac.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Virmmac.com is owned and operated by Virmmac.com. Neither Virmmac.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Virmmac.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Virmmac.com statements and opinions and such statements and opinions cannot be considered independent. Virmmac.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Virmmac.com services are often paid for using free-trading shares. Virmmac.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: http://www.Virmmac.com  on the bottom of the home page.

CONTACT:  Tel: 810-333-9159      e-mail: terri@virmmac.com

# # #

About Us

Virmmac, LLC (Virmmac.com) has created a platform that allows company management to interact effectively with current and potential shareholders, customers, and other media outlets through a seamless integration into an all-inclusive market and media website. We provide clients with the means to leverage their company’s profile to create a self-propagating audience for both their company and its stock.

Increasingly, established as well as new companies are recognizing the value of outsourcing their investor relations and strategic communication functions to a team of dedicated professionals. Communicating effectively with investors requires creativity, discipline, understanding trading issues and most importantly, daily interaction with potential investors. To be effective, market and media relations need to be in sync with broader strategic goals that support growing shareholder value.